The potential interaction between JAK2-mediated signaling pathways and cell cycle control functions modulated by CHEK2 could shed light on shared mechanisms or synergies in the pathogenesis of certain hematologic disorders and malignant neoplasms [6]. The gene discussed is CHEK2; the disease is cancer.